The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
You write more fiction than JK Rowling and Enid Blyton put together. Any newcomer simply has to read your post to realise you pump, change with the wind, and are paranoid of shorters.
How’s it all going. What you don’t understand is the fact that whoever is behind the scenes with the 60m, will be mates with Hemo exec and will make that plus over next two years just by being inside. So their risk is zero. Might make it as a bull or bear. TR1 count for nothing. RISK FACTORS RELATING TO THE GROUP’S FINANCIAL POSITION The Company has incurred significant losses in every year since its inception. The Company expects to continue to incur losses over the next several years and may never achieve or maintain profitability. RNS 7am
LSE shouldn’t delete this as it’s factual and contained within RNS: NOTE: The Company expects to continue to incur losses over the next several years and may never achieve or maintain profitability.
Well I am sorry, all these pumpers on here were stating it’s with the lawyers and Lilly will be working the weekend to put pen to paper.... Vickaroo stating SP almost £1 within 10 months.
Oh how you laughed: As at 28 January 2021, being the Latest Practicable Date, the Company had not received notice from GlobalCo to exercise the GlobalCo Option